BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20956829)

  • 1. The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy.
    Hwang ES
    J Natl Cancer Inst Monogr; 2010; 2010(41):197-9. PubMed ID: 20956829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ.
    Kane RL; Virnig BA; Shamliyan T; Wang SY; Tuttle TM; Wilt TJ
    J Natl Cancer Inst Monogr; 2010; 2010(41):130-3. PubMed ID: 20956816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
    Pyfer BJ; Jonczyk M; Jean J; Graham RA; Chen L; Chatterjee A
    Ann Surg Oncol; 2020 Sep; 27(9):3448-3455. PubMed ID: 32232706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective.
    Bijker N; van Tienhoven G
    J Natl Cancer Inst Monogr; 2010; 2010(41):178-80. PubMed ID: 20956825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the treatment of ductal carcinoma in situ of the breast.
    Baxter NN; Virnig BA; Durham SB; Tuttle TM
    J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysis.
    De Lorenzi F; Di Bella J; Maisonneuve P; Rotmensz N; Corso G; Orecchia R; Colleoni M; Mazzarol G; Rietjens M; Loschi P; Marcelli S; Veronesi P; Galimberti V
    Eur J Surg Oncol; 2018 Jul; 44(7):957-962. PubMed ID: 29759643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
    Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
    Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of DCIS treated with breast conserving surgery without radiotherapy on recurrence, survival, and health-related quality of life.
    Fitzpatrick SE; Eaton M; McLeay W; Dean NR
    ANZ J Surg; 2023 Sep; 93(9):2208-2213. PubMed ID: 37062870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
    Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast.
    Solin LJ
    J Natl Cancer Inst Monogr; 2010; 2010(41):187-92. PubMed ID: 20956827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of systemic therapy following ductal carcinoma in situ.
    Eng-Wong J; Costantino JP; Swain SM
    J Natl Cancer Inst Monogr; 2010; 2010(41):200-3. PubMed ID: 20956830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
    Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
    Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.
    Chuwa EW; Tan VH; Tan PH; Yong WS; Ho GH; Wong CY
    ANZ J Surg; 2008; 78(1-2):42-8. PubMed ID: 18199204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature.
    Vicini FA; Recht A
    J Clin Oncol; 2002 Jun; 20(11):2736-44. PubMed ID: 12039936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine Therapy Initiation and Medical Oncologist Utilization Among Women Diagnosed with Ductal Carcinoma in Situ.
    Anderson C; Meyer AM; Wheeler SB; Zhou L; Reeder-Hayes KE; Nichols HB
    Oncologist; 2017 May; 22(5):535-541. PubMed ID: 28408621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.